These data highlight the exciting potential of cagrilintide to offer an alternative approach for people to lose weight, achieve health-related outcomes and manage their obesity, including a favorable tolerability profile, lead investigator Timothy Garvey, M.D., study investigator and director of the Diabetes Research Center at the University of Alabama at Birmingham, said in the Sept
87990cbe856818d5eddac44c7b1cdeb8
Activity modificationavoiding movements that worsen symptoms while staying as active as possibleallows inflammation to subside
EV of A
Cheng X, Tan X, Wang W, Zhang Z, Zhu R, Wu M, et al
Results can appear gradually, often becoming more noticeable after a few sessions